Diffuse parenchymal lung disease

From Wikipedia, the free encyclopedia

**Diffuse parenchymal lung disease**
*Classifications and external resources*
ICD-10	J 68.4, J 70.1, J 84.1, P 27.8
ICD-9	506.4, 508.1, 515, 516.3, 714.81, 770.7
DiseasesDB	31509
eMedicine	ped/1950

Diffuse parenchymal lung disease (DPLD), also known as interstitial lung disease, refers to a group of lung diseases, affecting the alveolar epithelium, pulmonary capillary endothelium, basement membrane, perivascular and perilymphatic tissues. The term DPLD is used to distinguish these diseases from obstructive airways diseases. Most types of DPLD involve fibrosis, but this is not essential; indeed fibrosis is often a later feature. Hence the term pulmonary fibrosis has fallen out of favor.

1 Causes
2 Investigation
3 Treatment
4 External links

[edit] Causes

End-stage pulmonary fibrosis of unknown origin, taken from an autopsy in the 1980's.

DPLD may be classified according to the cause: -

Inhaled substances
- Inorganic
- Organic
  - Hypersensitivity pneumonitis
Drug induced
- Antibiotics
- Chemotherapeutic drugs
- Antiarrhythmic drugs
Connective tissue disease
Infection
- Atypical pneumonia
- Pneumocystis carinii pneumonia
- Tuberculosis
Idiopathic
Malignancy
- Lymphangitic carcinomatosis

[edit] Investigation

Investigation is tailored towards the symptoms and signs. Most patients have blood testing, chest x-ray, pulmonary function testing, and high resolution CT thorax.

[edit] Treatment

DPLD is not a single disease, but encompasses many different pathological processes. Hence treatment is different for each disease.

If a specific occupational exposure cause is found, the person should avoid that environment. If a drug cause is suspected, that drug should be discontinued.

Many idiopathic and connective tissue-based causes of DPLD are treated with prednisolone. Some patients respond to immunosuppressant treatment. Patients with hypoxemia may be given supplemental oxygen.